Active Targeting of Nanomedicines
- 10 November 2024
- book chapter
- Published by Springer Nature
- p. 337-385
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- Microfluidics: Fundamental, Devices and Applications2018
- Pharmaceutical Nanotechnology: Innovation and Production2016
- A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline SuspensionsJournal of Pharmaceutical Sciences, 2016
- Enhanced Tumor Targeting and Antitumor Efficacy via Hydroxycamptothecin-Encapsulated Folate-Modified N-Succinyl-N′-Octyl Chitosan MicellesJournal of Pharmaceutical Sciences, 2013
- Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene DeliveryAdvanced Materials, 2011
- The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?International Journal of Cancer, 2006
- Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinaseInternational Journal of Cancer, 2003
- Spiegelmers: Biostable AptamersChemBioChem, 2003
- Riboflavin carrier protein: A serum and tissue marker for breast carcinomaInternational Journal of Cancer, 2001
- Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implicationsCancer, 1994